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Abstract 
Background: Aurantimycin (ATM), produced by Streptomyces aurantiacus JA 4570, is a potent antimicrobial and anti-
tumor antibiotic. Although the chemical structure of ATM is highly distinctive and features a cyclohexadepsipeptide 
scaffold attached with a C14 acyl side chain, little is known about its biosynthetic pathway and regulatory mechanism.
Results: In this work, we report the identification and characterization of the ATM biosynthetic gene cluster from S. 
aurantiacus JA 4570. Targeted inactivation of artG, coding for a NRPS enzyme, completely abolished ATM production, 
thereof demonstrating the target gene cluster (art) is responsible for ATM biosynthesis. Moreover, four NRPS adenyla-
tion (A) domains including a freestanding enzyme ArtC have been characterized in vitro, whose substrate specificities 
are consistent with in silico analysis. Further genetic analysis of the two regulatory genes artB and artX unambigu-
ously suggested both of them play positive roles in ATM biosynthesis, and ATM-A production was thus rationally 
enhanced to about 2.5 fold via tandem overexpression of artB and artX in S. aurantiacus JA 4570.
Conclusions: These results will provide the basis for the understanding of precise mechanisms for ATM biosynthesis, 
and open the way for both rational construction of high-production ATM producer and orient-directed generation of 
designer ATM derivatives via synthetic biology strategies.
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Background
Aurantimycin (ATM), produced by Streptomyces auran-
tiacus JA 4570 (S. aurantiacus hereafter), was isolated in 
1994 in the process of screening for new ionophoric com-
pounds [1]. ATM exhibited high bioactivity against the 
gram-positive bacteria including Bacillus subtilis ATCC 
6633 (MIC 0.013 µg/mL) and Staphylococcus aureus 285 
(MIC 0.013 µg/mL), but gram-negative bacteria and fungi 
were not susceptible to this antibiotic [1]. Moreover, 
ATM showed cytotoxic effects against L-929 mouse 
fibroblast cells causing a sudden change from nontoxic to 
lethal concentrations ranging from 3 to 12 ng/mL [1].
ATM features a 19 membered cyclohexadepsipeptide 
core scaffold attached by a C14 acyl side chain. Structur-
ally, different ATM components share a distinctive struc-
tural feature with a tetrahydropyranyl-propionic acid 
acyl side chain linked to 2S, 3S-hydroxyleucine residue 
of the core scaffold via an exocyclic amide bond (Fig. 1) 
but differing in the extent of unsaturation of two oppo-
site piperazic acid moieties. Notably, despite the unique 
structure and diverse distribution of such moiety in 
natural products, the precise mechanism for its biosyn-
thesis remained unknown and confused biochemists for 
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decades. In addition, ATM also contains other nonpro-
teinogenic amino acids, such as N-hydroxy-L-alanine, 
N-hydroxy-L-serine, O-methyl-N-hydroxy-L-serine, and 
a proteinogenic amino acid glycine.
Structurally-related natural products, in the past dec-
ades, have been continuously discovered from Actin-
omycetes including A83586C [2], azinothricin [3], 
citropeptin [4], diperamycin [5], kettapeptin [6], IC101 
[7], L-156,602 [8], pipalamycin [9], polyoxypeptin [10] 
and variapeptin [11] (Fig.  1). Such group of secondary 
metabolites was designated as “azinothricin family” 
antibiotics as azinothricin, isolated from Streptomyces 
sp. X-1950 in 1986, was identified as the first member, 
and the biosynthetic gene cluster of polyoxypeptin has 
been recently reported by Du et  al. [12]. Attractively, 
this family of secondary metabolites exhibited diverse 
biological activities, including potent antibacterial, 
antitumor [13, 14], anti-inflammatory activities [15], 
and acceleration of wound healing [16]. The majority of 
azinothricin-family members showed powerful antitu-
mor effects [17]. For example, (+)-GE3 [13] could exert 
substantial antitumor effects against BALB/c-nu/nu 
nude mice xeno grafted with currently incurable PSN1-
human pancreatic carcinoma that a single 2  mg  kg−1 
dosage of (+)-GE3 was found to produce a 47 % reduc-
tion in tumor volume (11  days post-treatment), and 
none of the treated animals died as a result of receiving 
the drug [17].
Although the remarkable pharmacological activity and 
distinctive structure are intriguing, the ATM biosynthetic 
gene cluster has not been unearthed and the precise bio-
synthetic mechanism also remained obscure. Here we 
describe the characterization of the ATM biosynthetic 
gene cluster as well as the rational enhancement of its 
production. Genetic and biochemical experiments cou-
pled with bioinformatics analysis demonstrated the 
essential role of the gene cluster involved in ATM bio-
synthesis, thereof leading to a proposed pathway for 
ATM biosynthesis. Further rational enhancement of 
ATM production has also been realized by tandem over-
expression of the two pathway-specific regulatory genes 
artB and artX. The availability of the ATM biosynthetic 
gene cluster will lay a solid foundation for the mechanis-
tic insight of ATM biosynthesis, and pave the way for the 
construction of high-producing industrial strains and for 
the rational generation of the designer ATM derivatives 
with enhanced/selective bioactivity via synthetic biology 
strategies.
Fig. 1 Chemical structures of ATM, and other related azinothricin-family antibiotics
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Results and discussion
Identification and analysis of the aurantimycins gene 
cluster (art)
ATM shares a similar cyclohexadepsipeptide scaffold to 
polyoxypeptin, whose biosynthetic pathway has been 
previously identified from Streptomyces sp. MK498-
98 F14 [12], implicating that some specific enzymes, 
in particular NRPSs, of both pathways should exhibit 
certain homology. Accordingly, we utilized the NRPSs 
(PlyF, PlyG and PlyH) from polyoxypeptin pathway as 
individual probes to conduct the Blastp analysis against 
the genome of S. aurantiacus, which directly resulted 
in the identification of a continuous region in seq 14 
(NZ_AOPZ01000014.1) involving homologs desig-
nated as ArtF (STRAU_0335, 55  % identity to PlyF), 
ArtG (STRAU_0336, 51  % identity to PlyG) and ArtH 
(STRAU_0337, 43  % identity to PlyG). Further looking 
through the context of the target region, other proteins 
(ArtE and ArtI) also show significant homologies to their 
counterparts (PlyE and PlyI) in polyoxypeptin pathway, 
all of these implicated that the target gene cluster is most 
likely involved in ATM biosynthesis.
To test our postulation’s validity, artG (encoding a 
NRPS enzyme) disruption plasmid pWHU1143 was 
constructed (Fig.  2b) and introduced into S. aurantia-
cus via conjugation. On the basis of the standard proto-
cols, the mutant WL01 was screened and validated by 
PCR (Fig.  2c). After fermentation, the extract samples 
of WL01 and wild type strains were submitted for HPLC 
analysis. As expected, the sample of WL01 mutant was 
not capable of generating the characteristic ATM-A peak 
(Fig.  2d; Additional file  1: Figure S1), thus demonstrat-
ing that the target gene cluster is responsible for ATM 
biosynthesis.
Bioinformatic analysis revealed that seq 14 (NZ_
AOPZ01000014.1), comprising 36 deduced open read-
ing frames (ORFs) (Table 1), probably houses the entire 
ATM biosynthetic gene cluster (Fig.  2a). Amongst of 
them, there are 4 putative NRPS genes (artTFGH) encod-
ing 6 modules responsible for the template-synthesis of 
hexadepsipeptides, 4 PKS genes (artOPQR) for 4 mod-
ules that perfectly match the assembly line of C14 acyl 
chain based on the collinearity hypothesis [18], and it has 
5 ORFs for 5 free-standing modules including one ade-
nylation (A) domain (ArtC), two peptidyl carrier protein 
(PCP) domains (ArtD and ArtL), and two thioesterase 
(TE) domains (ArtI and ArtN) for participating in post-
translational modification or the formation of special 
monomers. In addition, it also contains one ORF for 
MbtH-like protein (ArtA), two ORFs for ATP-binding 
cassette (ABC) transporter (ArtJ and ArtK), and two 
ORFs for potential regulatory proteins (ArtB and ArtX).
ArtB and ArtX are the positive regulators during ATM 
biosynthesis
Within the art gene cluster, there are two putative 
regulatory genes artB and artX speculated to govern 
ATM production. Between them, ArtB shows signifi-
cant homology to a large family of uncharacterized 
potential regulators (Additional file  1: Figure S2) and 
was conjectured to be a novel pathway-specific regula-
tor class. Secondary structural analysis using SWISS-
MODEL [19] indicated that it had a HTH motif, which 
was likely to bind to promoter region of the target gene 
to participate in regulating process. artX, located in 
the right end of the cluster, was deduced to encode a 
TetR-like protein, which displayed high identity to 
other TetR-family regulators (TFRs) (90  % identity to 
ADK58_14020 of Streptomyces sp. XY152). Accord-
ing to the analysis by online program ESPript 3.0 [20], 
ArtX might contain nine potential helixes (Additional 
file 1: Figure S4).
To functionally characterize the two putative regula-
tors, the disruption vectors pWHU1144 (Additional file 1: 
Figure S3A) and pWHU1145 (Additional file  1: Figure 
S5A) were individually constructed and conjugated into 
S. aurantiacus. According to the standard methods [21], 
the individual mutants of artB and artX were screened 
and further confirmed by PCR (Additional file 1: Figures 
S3B, S5B). The artB and artX mutants, correspondingly 
designated as WL02 and WL03, were inoculated for fer-
mentation. Subsequently, the fermentation broth of the 
mutants and wild type strain were purified for HPLC 
analysis. The results showed that the ATM-A production 
by WL02 mutant decreased to about 45  %, and that by 
WL03 was significantly reduced to only 10 % (Fig. 3a, b; 
Additional file 1: Table S3). When the mutants were com-
plemented by individual genes (cloned into pIB139), the 
ATM-A production for the both complemented strains 
were partly restored (Fig. 3a, b). All of these data demon-
strated that both of ArtB and ArtX are the pivotal activa-
tors in ATM biosynthesis.
Actually, TetR-family regulators (TFRs) are widespread 
in Actinomycetes to serve as either activators or repres-
sors during secondary metabolite biosynthesis, and 
certain species of actinomycetes have over 100 TFRs, 
including S. coelicolor (153 TFRs), Streptomyces avermiti-
lis (115 TFRs), and Streptomyces griseus (104 TFRs) [22]. 
They consist of two domains: a conserved helix-turn-
helix DNA binding domain (DBD) close to N-terminus, 
and a C-terminal bacterial transcriptional activation 
domain (BTAD) that displays broad sequence and struc-
tural variation and interacts with a wide variety of ligands 
[23]. In this respect, ArtX might act in a similar way to 
control ATM biosynthesis.
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Overexpression of artB or/and artX boosts ATM production
Since both ArtB and ArtX are the positive regulators to 
control ATM biosynthesis, introduction of an extra copy 
of them is probably a feasible way to increase the antibi-
otic production. To test this speculation, artB and artX, 
therefore, were independently cloned into pIB139 under 
the  control of PermE* and then the resultant plasmids 
were conjugated into the wild type strain of S. auran-
tiacus. After PCR confirmation (Additional file 1: Figure 
S6A, S6B), the conjugants (WT::artB and WT::artX) were 
inoculated for fermentation for 5 days. Subsequently, the 
extract samples of the fermentation broth were subjected 
for HPLC analysis. Conforming to the anticipation, intro-
duction of an extra copy of artB or artX was capable of 
increasing the ATM-A production to 1.9- and 2.0-fold 
(Fig. 4a, b; Additional file 1: Table S4).
Rewarded by the production enhancement via artB 
or artX overexpression, we were promoted to ponder 
if we could construct higher yield strains by simultane-
ously manipulating the two activators. Then we tandemly 
overexpressed both artB and artX in wild type strain of 
S. aurantiacus. The validated recombinant strains (Addi-
tional file  1: Figure S6C) were inoculated for fermenta-
tion, and the extract sample of the recombinant WT::artB 
& artX were submitted for HPLC evaluation. The results 
indicated that ATM-A production by WT::artB & artX 
was increased to ca. 2.5-fold compared with that of the 
wild type strain (Fig.  4a, b). All these illustrated that 
simultaneous overexpression of two positive regula-
tory genes was a feasible and effective approach for the 
rational enhancement of ATM-A production, and might 
be extended for the overproduction of other industrially 
and clinically important antibiotics.
Adenylation (A) domain activity assays define their 
independent roles for ATM biosynthesis
A domains function as the gatekeepers of NRPSs since 
they select, activate, and then install the carboxylic acid 
substrates onto the adjacent PCP domain in the biosyn-
thesis of nonribosomal peptides. And analysis of primary 
sequence and key amino acid residues of substrate-bind-
ing pockets of these domains allows for the prediction of 
A domains preferences. Within the art gene cluster, the 
A domains have predicted substrate specificities in agree-
ment with the cyclodepepsipeptides scaffold of ATM. 
To test the proposed specificities of four A domains of 
seven, ArtC, ArtF-A2, ArtG-A1, ArtH-A were individu-
ally overexpressed and purified from E. coli (Additional 
Fig. 2 Organization and confirmation of the ATM biosynthetic gene cluster. a Organization of the ATM gene cluster. The proposed gene functions 
are listed in Table 1. b Schematic construction of the ΔartG mutant WL01. c Confirmation of the ΔartG mutant WL-01 by PCR. 1 wild type; 2 the ΔartG 
mutant WL01; M, 1 kb ladder. d HPLC analysis of the extract samples of S. aurantiacus JA 4570 wild type and the mutant WL01
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file 1: Figure S7), and further tested their substrate activi-
ties in vitro. The results indicated that the most favora-
ble substrate for ArtF-A2 is L-Ser, while the preferred 
amino acids for ArtG-A1 and ArtH-A are Gly and L-Ala, 
respectively (Fig. 5). All of the data were fully consistent 
with the results of bioinformatic analysis.
More notably, we revealed that ArtC is a freestand-
ing. A domain enzyme in the ATM biosynthetic pathway, 
Table 1 Deduced functions for the orfs in ATM biosynthetic gene cluster
Orf1(STRAU_0320)…………Orf12(STRAU_0357)
a Numbers are in amino acids
Protein Sizea Accession no. Proposed function Homolog. origin Identity/similarity
Orf1 206 EFE72573 Sugar transporter SSFG_07808, Streptomyces ghanaensis ATCC 14672 82/88
Orf2 91 EME58614 Phosphopantetheine attachment site 
domain-containing protein
H074_18583, Amycolatopsis decaplanina DSM 
44594
35/65
Orf3 181 AKJ15912 NADH: riboflavin 5′-phosphate oxidore-
ductase
ABB07_39600, Streptomyces incarnatus 57/67
Orf4 393 EFE72565 Cytochrome P450 hydroxylase SSFG_07800, Streptomyces ghanaensis ATCC 14672 76/88
Orf5 378 KTF47283 Zinc-binding dehydrogenase APS67_01215, Streptomyces sp. AVP053U2 82/90
Orf6 312 EFE73053 3-Oxoacyl-[acyl-carrier-protein] synthase III SSGG_00419, Streptomyces roseosporus NRRL 
15998
71/82





Orf8 77 XP_008613423 Dihydrolipoamide succinyltransferase SDRG_09281, Saprolegnia diclina VS20 44/62
Orf9 326 KOX10942 2-Oxoisovalerate dehydrogenase ADK66_07235, Micromonospora sp. NRRL B-16802 50/64
Orf10 279 KTF47288 3-Methyl-2-oxobutanoate dehydrogenase APS67_01220, Streptomyces sp. AVP053U2 86/91
ArtA 71 KOG32626 MbtH-like protein ADK37_26530, Streptomyces resistomycificus 87/94
ArtB 240 KUN90566 Putative regulator AQJ84_39630, Streptomyces resistomycificus 77/86
ArtC 530 KUM93570 A AQI88_26200, Streptomyces cellostaticus 84/90
ArtD 77 AKJ15824 PCP ABB07_39115, Streptomyces incarnatus 84/90
ArtE 395 KUM93571 FAD-dependent oxidoreductase AQI88_26210, Streptomyces cellostaticus 81/90
ArtF 2882 KUM93572 C-A-PCP-E-C-A-MT-PCP AQI88_26215, Streptomyces cellostaticus 81/88
ArtG 2574 KOU40387 C-A-PCP-E-C-A-PCP ADK54_22435, Streptomyces sp. WM6378 78/86
ArtH 1274 KJY47954 C-A-PCP-TE VR46_00735, Streptomyces sp. NRRL S-444 78/87
ArtI 248 KUM93575 TE AQI88_26230, Streptomyces cellostaticus 86/90
ArtJ 312 KOG32633 ABC transporter ADK37_26575, Streptomyces resistomycificus 86/92
ArtK 253 KIF05972 ABC transporter permease PL81_10120, Streptomyces sp. RSD-27 81/92
ArtL 73 KUM93581 PCP AQI88_26270, Streptomyces cellostaticus 86/90
ArtM 416 KUM99154 Cytochrome AQI95_40375, Streptomyces yokosukanensis 89/93
ArtN 245 KUM93583 TE AQI88_26280, Streptomyces cellostaticus 79/87
ArtO 1034 KUM93584 KS-AT-ACP AQI88_26285, Streptomyces cellostaticus 80/86
ArtP 1899 KUM93585 KS-AT-DH-KR-ACP AQI88_26290, Streptomyces cellostaticus 71/79
ArtQ 2199 KUM93586 KS-AT-DH-ER-KR-ACP AQI88_26295, Streptomyces cellostaticus 77/85
ArtR 1040 KJY47935 KS-AT-ACP VR46_00775, Streptomyces sp. NRRL S-444 81/89
ArtT 1061 KUM93588 C-A-PCP AQI88_26305, Streptomyces cellostaticus 72/81
ArtU 248 AGK78157 DUF1838 SFUL_3223, Streptomyces fulvissimus DSM 40593 89/93
ArtV 260 KUL64059 Peptidoglycan-binding protein ADL30_00970, Streptomyces sp. NRRL S-1521 77/83
ArtW 116 CAJ88026 Conserved hypothetical protein SAMR0316, Streptomyces ambofaciens ATCC 23877 78/82
ArtX 209 KOT40573 TetR family Transcriptional regulator ADK41_12650, Streptomyces caelestis 90/93
Orf11 467 AJE84472 Integrin-like protein SLNWT_4096, Streptomyces albus 82/88
Orf12 261 AGM04325 Putative ArsR family transcriptional regula-
tor
AORI_1737, Amycolatopsis orientalis HCCB10007 45/60
Orf13 176 AKJ08646 Hypothetical protein ABB07_00890 ABB07_00890, Streptomyces incarnatus 49/62
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implicating that such enzyme is most likely to harbor the 
function of trans-activating more than one amino acids. 
To validate such hypothesis, we test its activity in  vitro 
with five selected substrates, and the results indicated 
the most preferred substrate for this enzyme is L-Val, and 
interestingly the other two amino acids L-Ser and L-Leu 
can also be recognized and activated by the enzyme. 
These combined data are completely matched with the 
A domain predication results and the assembly logic for 
ATM biosynthesis.
Biosynthesis and assembly of the C14 acyl side chain
Within the art cluster, the organization of 4 type I PKS 
modules encoded by artOPQR coincides with the assem-
bly line of the C14 acyl side chain of ATM via three steps 
of elongation from the propionate starter unit (Fig.  6a). 
Fig. 3 Genetic characterization of artB and artX as positive regulatory 
genes for ATM biosynthesis. a HPLC analysis of ATM-A production by 
related recombinants of S. aurantiacus. WT, wild type S. aurantiacus JA 
4570; ΔartB, the ΔartB mutant WL02 of S. aurantiacus; ΔartB::pIB139, 
ΔartB mutant WL02 containing pIB139 as negative control; ΔartB::artB, 
ΔartB mutant WL02 containing pIB139/artB for complementation; 
ΔartX, the ΔartX mutant WL03 of S. aurantiacus; ΔartX::pIB139, ΔartX 
mutant WL03 containing pIB139 as negative control; ΔartX::arX, ΔartX 
mutant WL03 containing pIB139/artX for complementation; b Com-
parative analysis of ATM-A production produced by related recomni-
ants of S. aurantiacus. All measurements were conducted in triplicate
Fig. 4 Individual overexpression of artB, artX as well as artB & artX in S. 
aurantiacus remarkably enhances ATM-A production. a HPLC analysis 
of the ATM-A production by relevant S. aurantiacus recombinants. b 
Comparative analysis of the ATM-A production by target strains. WT, 
S. aurantiacus wild type; WT::pIB139, S. aurantiacus containing pIB139 
as negative control; WT::artX, S. aurantiacus containing pIB139/artX; 
WT::artB, S. aurantiacus containing pIB139/artB; WT::artB & artX, S. 
aurantiacus containing pIB139/artB & artX. All measurements were 
conducted in triplicate
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Both ArtO and ArtR consist of ketosynthase (KS), acyl-
transferase (AT), and acyl carrier protein (ACP). How-
ever, the active site Cys (for trans thioesterification) of 
the ArtO-KS is substituted with Gln, a devitalizing phe-
nomenon named “KSQ” that often occurs in the loading 
module of PKS system [24] (Additional file 1: Figure S8). 
Therefore, ArtO serves as a loading module for the for-
mation of propionate starter unit by catalyzing decarbox-
ylation of methylmalonyl group after tethering onto ACP 
(Fig. 6a). The conserved regions of AT domain including 
the active motif GHSQG [25] in both ArtO and ArtR, 
along with substrate specificity code YASH [26] indi-
cate that both ATs are specific for methylmalonyl-CoA, 
consistent with the structure of the side chain of ATM 
(Fig. 6a).
ArtQ, consisting of an active DH domain, an ER 
domain, and an AT domain, contains the active site 
HAFH, so it was assumed to specifically recognize mal-
onyl-CoA as the extender. In ArtP, except for three core 
domains KS, AT, and ACP, a dehydratase (DH) domain 
and a ketoreductase (KR) are also present. On the basis 
of collinearity of the domain architecture to the ATM 
structure, the DH domain here is believed to be non-
functional, however, why this confusing phenomenon 
occurs in ATM assembly line remained unknown. In 
addition, the conserved motif of ArtP-AT for sub-
strate selectivity is VPGH, neither the serine residue 
in YASH for methylmalonyl-CoA nor phenylalanine 
residue in HAFH for malonyl-CoA. These changes may 
broaden the substrate binding pocket and enhance its 
hydrophobicity, supporting that ArtP likely recognizes 
2-(2-methylpropyl) malonyl-CoA as unusual extender 
unit (Fig. 6b).
Assembly of the cyclodepepsipeptide by NRPSs
After the C14 acyl side chain is synthesized by 4 modular 
PKSs, it is transferred to 3-hydroxyleucine with forma-
tion of an amide bond catalyzed by ArtT, thus initiating 
the assembly of the peptide core architecture. The art 
gene cluster encompasses four genes artTFGH coding for 
a multimodular NRPS that comprises 6 extension mod-
ules, in agreement with 6 condensation steps required for 
the biosynthesis of the ATM cyclodepsipeptide scaffold 
(Fig. 6a).
Both ArtF and ArtG consist of two modules that are 
correspondingly composed of seven domains (C-A1-
PCP-E-C-A2-PCP) (Fig.  6a). The ArtF-A1 and ArtG-
A2 are proposed to recognize and activate L-piperazic 
acid that was speculated to be derived from L-ornithine 
[27]. This assumption can be supported by the findings 
that ArtF-A1 shares 52–66  % identity with ArtG-A2, 
HmtL-A1, and KtzH-A1 (Additional file  1: Figure S10); 
more convincingly, the conserved substrate specificity-
conferring amino acids (DVFSVASYAK for ArtF-A1, 
DVFTVAAYAK for ArtG-A2) are highly analogous to 
those of KtzH-A1 (DVFSVGPYAK) and HmtL-A1 (DVF-
SVAAYAK), which were reported to recognize and acti-
vate piperazic acid in previous studies [28, 29]. All of 
these suggested that ArtF-A1 and ArtG-A2 are probably 
to specifically recognize and transfer piperazic acid to the 
corresponding PCP domain.
In the middle of the modules of ArtF and ArtG, an 
active epimerase (E) domain is present, indicating that 
the amino acids activated by ArtF-A1 and ArtG-A1 
should be converted in D-configuration. Confusingly, 
the very amino acid activated by ArtG-A1 is glycine in 
actual, which means the E domain, either functional or 
Fig. 5 Substrate specificities of four adenylation domains ArtC, ArtF-A2, ArtG-A1, and ArtH-A in vitro. NC, no amino acid substrate. All amino acid 
substrates (4 mM) are L type, unless otherwise indicated. The background has been subtracted. Error bars represent standard deviations from three 
independently performed experiments
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nonfunctional, could not affect the configuration of this 
building block, but why an E domain present in the ArtG 
enzyme remains mysterious. Moreover, this may be also 
the reason that two piperazic acids have opposite config-
urations in ATM.
There is an O-methylation in the L-Ser residue of ATM 
which is usually catalyzed by an O-methyltranferase. 
Scanning through the whole art gene cluster, while we 
did not identify the target enzyme likely involved in such 
methylation, therefore we reinvestigated the domain 
organization of ArtF, rendering the discovery of a meth-
yltransferase (MT) domain which was proposed to be 
responsible for the O-methylation during the assembly of 
cyclohexadepsipeptide scaffold.
As for ArtH, it contains four domains (C-A-PCP-TE) as 
predicated by in silico analysis, the terminal TE domain 
present in ArtH strongly demonstrated that this enzyme 
was the last module of ATM NRPS-template system and 
responsible for the release and cyclization of the peptide 
chain via ester bond formation.
Biosynthesis of the unusual extender unit 2
Based on the structural analysis of ATM architecture, a 
2-(2-methylpropyl) malonyl extender unit (2) is prob-
ably incorporated into the assembly line of C14 moiety. 
Investigation of the art gene cluster, orf2-orf10 (Fig. 2a), 
surprisingly, are completely matched to those in polyoxy-
peptin gene cluster, in either organization or homology. 
Thus, we concluded that those genes were responsible for 
the unusual moiety’s biosynthesis (Fig. 6b).
For the initiating the biosynthesis of the unusual 
extender unit, L-Val was deduced as the starter sub-
strate which was followed by a transamination to form 
compound 2, whereas we could not assign an obvi-
ous protein from the ATM pathway for such catalyzed 
step. Similar reaction has been reported for forma-
tion of the 2-(2-methylbutyl) malonyl unit of polyoxy-
peptins derived from isoleucine [27]. After that, the 
chain of 3 was believed to elongate by condensation 
with α-keto acid catalyzed by Orf6, a protein shares 

























































































































































































































































Fig. 6 Proposed biosynthetic pathway for ATM. a The proposed model for ATM scaffold assembly line driven by the hybrid PKS/NRPS system. KS 
ketosynthase, AT acyltransferase, ACP acyl carrier protein, DH dehydratase, KR ketoreductase, ER enoylreductase, A adenylation domain, PCP peptidyl 
carrier protein, C condensation domain, MT methyltransferase domain, E epimerase domain, TE thioesterase domain. b The proposed pathway for 
the biosynthesis of 2-(2-methylpropyl)malonyl-ACP; c The proposed pathway for the biosynthesis of the nonproteinogenic amino acids building 
blocks
Page 9 of 12Zhao et al. Microb Cell Fact  (2016) 15:160 
that was a 3-oxoacyl-[acyl-carrier-protein] synthase III 
from Streptomyces roseosporus NRRL 15998, with the 
assistance of Orf7 as speculated as a phosphopanteth-
eine attachment site containing protein. Within the art 
gene cluster, orf9 codes for a 2-oxoisovalerate dehydro-
genase homolog to ADK66_07235 of Micromonospora 
sp. NRRL B-16802 (identity/similarity, 50/64  %), and 
orf10 for a 3-methyl-2-oxobutanoate dehydrogenase to 
APS67_01220 from Streptomyces sp. AVP053U2 (iden-
tity/similarity, 89/91  %), and they might mediate the 
previous acylation reaction. Then the gene orf5 encodes 
a zinc-binding dehydrogenase, suggesting it might par-
ticipate in the subsequent intermediate’s ketoreduction. 
Finally, the generation of 2-(2-methylpropyl)malonyl 
unit (4) would involve a crotonyl-like reductive carbox-
ylation mediated by some endoreductases homologs, 
although no such gene have been found in the art gene 
cluster (Fig. 6b).
Biosynthesis of the nonproteinogenic amino acid building 
blocks
Except for the modular NRPSs, there are five free-stand-
ing genes present in the art gene cluster deduced to indi-
vidually encoding an A domain (ArtC), two PCP domains 
(ArtD and L) and two TE domains (ArtI and N). Since 
the discrete NRPS domains found in many NRPS assem-
bly lines are often responsible for the formation of non-
proteinogenic building blocks [18]. These enzymes were 
assumed to catalyze the generation of these monomers 
from natural amino acids, and ArtC was characterized 
to activate multiple amino acids as Ala, Ser, and Val, and 
tether them to the corresponding PCPs (ArtD or ArtL). 
After N-hydroxylation of serine and alanine (6/7) as well 
as β-hydroxylation of leucine (8), the matured building 
blocks are proposed to be released by discrete TEs, either 
ArtI or ArtN (Fig. 6c), and then activated by the subse-
quent corresponding modular A domains for the assem-
bly of the ATM scaffold.
Piperazic acid is an attractive building block of many 
complex secondary metabolites such as antrimycin [30], 
chloptosin [31], himastatin [32], luzopeptin [33], qui-
noxapeptin [34], lydiamycin [35], piperazimycin [36] and 
sanglifehrin [37], while the detailed piperazic acid biosyn-
thetic mechanism still remained poorly understood yet. 
Previously, Walsh and coworkers demonstrated that KtzI, 
a homolog of lysine/ornithine N-hydroxylases catalyzed 
the conversion of ornithine into N-hydroxy-ornithine 
[38, 39], but how this intermediate was further utilized to 
form piperazic acid remained totally unknown and con-
fused the biochemists for over half a century (Fig. 6c).
The tailoring steps for ATM biosynthesis
After maturation, the ATM precursor was released by TE 
domain of the NRPS assembly line, whereas it needs fur-
ther tailoring steps for the fulfillment of the ATM biosyn-
thesis. Within the art gene cluster, a candidate gene orf4 
coding for a  cytochrome P450 hydroxylase was tenta-
tively assigned to be responsible for the tailoring hydrox-
ylation to synthesize the matured ATM-A. Interestingly, 
three ATM components (ATM-A, B and C) differed in 
the extent of unsaturation of two opposite piperazic acid, 
but how such enzymatic reaction (oxidation/reduction) 
occurs remained enigmatic.
Conclusions
Azinothricin family natural products have spurred an 
increasing interest in recent years due to their unusual 
structural features and diverse bioactivities. However, the 
knowledge on the biosynthetic gene cluster and pathway 
of this family of antibiotics is limited. In combination of 
genetic, biochemical, and bioinformatics analysis, we 
report the identification and characterization of the ATM 
biosynthetic gene cluster, and delineate the proposed 
assembly line for ATM biosynthesis. More importantly, 
we illustrate the positive roles of ArtB and ArtX in ATM 
biosynthesis, and further realize the rational enhance-
ment of ATM production via tandem overexpression of 
artB and artX. We anticipate that manipulation of the 
ATM pathway would be of great potential to generate 
novel ATM-based antibiotics with enhanced activity and 
modified selectivity.
Methods
Bacterial strains, plasmids, and culture conditions
Bacterial strains and plasmids used in this study are 
listed in Table S1 and the relevant PCR primers in Table 
S2. Escherichia coli strains including DH10B, ET12567/
pUZ8002, and Rossetta (DE3) were cultivated at 37  °C 
in Luria–Bertani (LB) liquid medium or on LB agar. S. 
aurantiacus JA 4570 and its derivatives were cultured 
at 28  °C in TSBY (yeast extract 5 g/L, tryptic soy broth 
30  g/L, sucrose 103  g/L) for DNA extraction and on 
Mannitol-Soybean (MS) agar for sporulation and genetic 
manipulation. For fermentation, mycelia of the strain JA 
4570 and its derivatives were inoculated in fermentation 
medium (soybean powder 20 g/L, glucose 10 g/L, NaCl 
5 g/L, CaCO3 3 g/L, pH7.2) and cultivated at 28  °C for 
5 days. When necessary, the medium was supplemented 
with apramycin 30  μg/mL, chloramphenicol 25  μg/mL, 
kanamycin 50 μg/mL, thiostrepton 12.5 μg/mL, or ampi-
cillin 100 μg/mL.
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Construction of the target mutants
For the construction of the target mutants, the target 
gene disruption plasmids were transformed into E. coli 
ET12567/pUZ8002 cells, and the conjugation between 
E. coli ET12567/pUZ8002 and S. aurantiacus was per-
formed on MS medium. The exconjugants confirmed 
by PCR were further inoculated in a new TSBY without 
antibiotic added for 8 days. Subsequently, all the mutant 
strains in this study were generated and screened accord-
ing to the standard method [21]. The randomly selected 
thiostrepton-resistant and apramycin-sensitive candi-
dates were confirmed by PCR with corresponding prim-
ers listed in Additional file 1: Table S2.
Complementation of the artB or artX mutants 
and construction of artB or/and artX overexpression strains
All the overexpression strains are generated by lysogenic 
recombination according to the standard method [21]. 
For the complementation of artB or artX mutants, the tar-
get gene artB or artX was cloned into the vector pIB139 
under control of PermE*. After confirmation, the recom-
binant plasmid was transformed into E. coli ET12567/
pUZ8002 cells. Then artB (artX) cloned in pIB139 was 
conjugated into artB (artX) mutant or conjugated into 
wild type strain of S. aurantiacus for ATM overproduc-
tion. For the tandem overexpression of artB and artX, 
pWHU1149 containing artB and artX was conjugated into 
S. aurantiacus for ATM overproduction. The exconju-
gants would appear three days later and the exconjugants 
confirmed by PCR with corresponding primers were cul-
tivated for further fermentation.
HPLC analysis of ATM production
After fermentation, the culture broth was centrifuged 
and the mycelium pellet was extracted by 5 volume of 
methanol overnight. The supernatant of methanol phase 
was concentrated to 25  mL by rotary evaporator under 
the reduced pressure, then 25 mL H2O and 50 mL n-hex-
ane were added for the first extraction. Subsequently, 
the product was extracted by 50  mL trichloromethane 
in the second extraction. Finally, trichloromethane was 
swapped-off by the rotary evaporator and then the residue 
was dissolved in methanol (500  μL) for HPLC analysis. 
The HPLC analysis was conducted on a Shimadzu LC-
20A equipped with a SB-18 column (Shimadzu, 3.5  µm, 
4.6 × 250 mm), the conditions are as follows: 80 % B (iso-
cratic elution, solvent B is acetonitrile) at the flow rate of 
0.5 mL/min with reverse-phase column at 28 °C.
Adenylation domain cloning, expression, purification, 
and assays
Structural genes containing the corresponding ade-
nylation domains ArtF-A2, ArtG-A1 and ArtH-A, and 
independent A domain protein ArtC were amplified 
from S. aurantiacus genome DNA via KOD Fx high fidel-
ity PCR polymerase (TOYOBO) with individual pair of 
primers listed in Additional file 1: Table S2. The Purified 
PCR products were first cloned into pEASY Blunt vector, 
after confirmation by DNA sequencing, the related NdeI-
EcoRI engineered structural genes were individually 
cloned into pET-28a (+) following standard protocols. 
The resulting expression constructs were subsequently 
transformed into E. coli Rosetta (DE3) cells, and the 
resulting transformants were grown in LBBS medium 
(Betaine 0.309 g/L, Sorbitol 185.9 g/L, yeast extract 5 g/L, 
tryptone 10 g/L, NaCl 5 g/L) supplemented with antibi-
otics kanamycin 50  μg/mL and chloromycin 25  μg/mL. 
Expression and purification for all His6-tagged proteins 
followed the same general procedures and is described 
as follows: in 1  L of liquid  LBBS culture, the cells were 
grown at 37 °C until the OD600 of 0.6–0.8. The cells were 
cooled on ice for 10 min, and then induced with 0.12 mM 
IPTG for 72 h at 15 °C at 220 r. After that, the cells were 
harvested by centrifugation (5000  rpm, 10  min, 4  °C), 
resuspended in 30  ml lysis buffer (25  mM Tris, pH 8.0, 
150  mM NaCl, 5  mM imidazole) and lysed by homog-
enization on ice. Cellular debris was removed by cen-
trifugation (10,000 r/min, 40  min, 4  °C). The soluble 
proteins were incubated with 2  ml of Ni–NTA agarose 
resin (Qiagen), nutated in the ice overnight, and loaded 
onto a gravity flow column. The proteins were washed 
with washing buffer (25 mM Tris, pH 7.8, 150 mM NaCl) 
and eluted with elution solution (25  mM Tris, pH 7.8, 
150  mM NaCl, and 200  mM imidazole). Purified pro-
teins were concentrated and buffer exchanged into pro-
tein stock buffer (25  mM Tris, pH 8.0, 150  mM NaCl, 
and 10 % glycerol) using Amicon Ultra filters. Finally, the 
proteins were flash-frozen in liquid nitrogen and stored 
at −80 °C for further use.
ATP-PPi exchange assays were conducted by Enz-
check Pyrophosphate Assay Kit (E-6645) purchased from 
Thermo Fisher Scientific. Reaction was initiated by add-
ing purified protein to a final concentration of 2  μΜ. 
After incubating at 22  °C for 45 min, the mixtures were 
transferred to 96-well plates and measured at 360 nm by 
Infinite M2000 Pro (TECAN).
In silico analysis of the ATM gene cluster
The genome contig sequence was obtained from 
National Center for Biotechnology Information (NCBI) 
with accession number NZ_AOP01000014.1, and the 
deduced open reading frames (ORFs) were analyzed with 
the FramePlot 4.0beta online program (http://nocar-
dia.nih.go.jp/fp4/) [40]. The function of putative pro-
teins were deduced via homology-based analysis using 
the basic local alignment search tool (BLAST) program 
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(http://www.ncbi.nlm.nih.gov/blast/) [41]. The NRPS-
PKS architecture was analyzed by PKS/NRPS analysis 
program (http://nrps.igs.umaryland.edu/) online [42]. 
The multiple sequence alignment and analysis were 
performed by ClustalW on-line program (http://www.
genome.jp/tools/clustalw/) [43]. The secondary struc-
ture was predicted by ESPript 3.0 (http://espript.ibcp.fr/
ESPript/ESPript/) [20] and Swiss-Model (http://swiss-
model.expasy.org/) [19].
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